Develop and manufacture biotherapeutics that address significant medical needs.
Government reimbursement for biotherapeutics. General health care reform issues.
Government reimbursement for biotherapeutics.
Comparative effectiveness research.
Legislative and regulatory issues involved in FDA approval of follow-on biologics. Legislative and regulatory issues involved in FDA approval of follow-on biologics. Comparative effectiveness research.
MMM - Medicare/Medicaid HCR - Health Issues PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TARPLIN STRATEGIES LLC
975 F Street NW Suite 500, Washington, DC, 20004, US
RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN RICHARD JOSEPH TARPLIN (and Families)
and Families and Families and Families